Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
Pharmacists warned to be on alert for coronavirus infections
Pharmacists are encouraged to get a travel history for patients presenting with flu-like symptoms, with five cases so far in Australia1 of the novel...
How Emily Shears MPS made her passion her profession
‘I want to live in a fair society where everyone gets the opportunity to bring their full selves [to work],' says Dr Esa Chen MPS.
ECPs win big at APSA awards
Two early career pharmacists were presented with 2022 Australasian Pharmaceutical Science Association awards at the PSA22 closing luncheon.
The program transforming regional and rural healthcare
A new program in a NSW Primary Health Network is providing pharmacist consultations to patients in rural and regional communities.
Minister Hunt commits to PSA being a signatory to 7CPA
Federal Minister for Health Greg Hunt has committed to PSA being a signatory of the Seventh Community Pharmacy Agreement (7CPA), due for commencement in...
Transforming transitions of care
The work of these award-winning South Australian pharmacists is having a real-world impact on patients.
